Recent

% | $
Quotes you view appear here for quick access.

iShares Silver Trust Message Board

  • jtdmnf533 jtdmnf533 Jun 28, 2013 12:14 PM Flag

    Next Week's Huge Percentage Gainer, Must Research ASAP!

    You must research Concurrent (CCUR) immediately! Big Data Analytics will become the hottest tech space on Wall Street this summer, with CCUR the Big Data stock that is set to make the largest short-term gains! Tableau Software (DATA) had its IPO last month at $31 and is now $56.41 up 82% from its IPO! DATA has a market cap of $3.24 billion with revenues of only $143mm! Splunk (SPLK) is now $47 up 176% from its IPO last year at $17, and has a market cap of $4.88 billion with revenues of only $219mm!

    CCUR's Big Data Analytics technology has the largest market share in the cable TV industry, already having processed a total of 15 billion media transactions of 35mm pay-TV subscribers! While DATA and SPLK are both trading for 22X sales despite having negative EPS - CCUR has positive, rapidly growing EPS - with revenues of $63.23mm - yet CCUR's enterprise value at $7.57 is only $43.9m or 0.69X sales! CCUR is also trading with an enterprise value of only 6X operating cash flow vs. DATA and SPLK having enterprise values of 224X and 77X operating cash flow, respectively! If CCUR had an enterprise value of just 2X sales and 18X operating cash flow, it would be $17 per share, up 125% from its current rock bottom share price!

    A must read new article "How Big Data Keeps Cable TV Watchers Hooked" features Time Warner Cable (TWC) and how they're using Big Data Analytics to determine the course of both their marketing efforts and network infrastructure. TWC is America's 2nd largest cable TV operator with 12mm subscribers and they are using CCUR's dynamic Big Data Analytics solutions! CCUR is so profitable and fundamentally strong that it just doubled its cash dividend and now pays an enormous dividend yield of 6.34% - more than double all comparable Big Data tech stocks!

 
SLV
15.39-0.14(-0.90%)May 27 4:00 PMEDT